Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis

HIGHLIGHTS

• who: Cristina Quereda from the Departamento de Fisiologu00eda, Genu00e9tica y Microbiologu00eda, Facultad de Ciencias, Alicante, Spain have published the research work: Involvement of abnormal dystroglycan expression and matriglycan levels in cancer pathogenesis, in the Journal: (JOURNAL)

SUMMARY

The non-covalent association of α-DG and β-DG occurs within the so-called SEA domain, located extracellularly between the DG mucin-like (ECM-binding) and transmembrane domains. The cytosolic portion of β-DG, i.e., its C-terminal domain, is anchored to the actin cytoskeleton through its interaction with dystrophin or utrophin, the latter a dystrophin paralog . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.